Apoptotic activity is increased in the newly formed fibromyxoid connective tissue in bronchiolitis obliterans organizing pneumonia

Lung

Volumn 177, Issue 6, 1999, Pages 367-376

  Lappi Blanco, E ^a   Soini, Y ^a   Pääkkö, Paavo ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Apoptosis; Bcl 2 family proteins; BOOP; Fibrotic lung disorder; UIP

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BRONCHIOLITIS; CONNECTIVE TISSUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY;

EID: 0032758102     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007654     Document Type: Article

References (29)

1. 1. Bardales RH, Xie S-S, Schaefer RF, Hsu S-M (1996) Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 149:845-852
2. 2. Basset F, Ferrans VJ, Soler P, Takemura T, Fukuda Y, Crystal RG (1986) Intraluminal fibrosis in interstitial lung disorders. Am J Pathol 122:443-461
3. 3. Bodrug SE, Aimé-Sempé C, Sato T, Krajewski S, Hanada M, Reed JC (1995) Biochemical and functional comparisons of mcl-1 and bcl-2 proteins: evidence for a novel mechanism of regulating bcl-2 proteins function. Cell Death Differ 2:173-182
4. 4. Burkhardt A (1989) Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am Rev Respir Dis 140:513-524
5. 5. Colby TV (1992) Pathologic aspects of bronchiolitis obliterans organizing pneumonia. Chest 102:38-43S
6. 6. Dail DH (1994) Tissue sampling. In: Dail DH, Hammar SP (eds) Pulmonary Pathology. New York, Springer-Verlag, pp 4-5
7. 7. Desmoulière A, Redard M, Darby I, Gabbiani G (1995) Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146:56-66
8. 8. Epler GR (1992) Bronchiolitis obliterans organizing pneumonia: definition and clinical features. Chest 102:2-6S
9. 9. Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA (1985) Bronchiolitis obliterans organizing pneumonia. N Engl J Med 312:152-158
10. 10. Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N (1998) Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest 78:687-698
11. 11. Guinee D Jr, Brambilla E, Fleming M, Hayashi T, Rahn M, Koss M, Ferrans V, Travis W (1997) The potential role of BAX and BCL-2 expression in diffuse alveolar damage. Am J Pathol 151:999-1007
12. 12. Guinee D Jr, Fleming M, Hayashi T, Woodward M, Zhang J, Walls J, Koss M, Ferrans V, Travis W (1996) Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. Am J Pathol 149:531-538
13. 13. Katzenstein A-LA (1997) In: Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease, 3rd ed. Philadelphia, WB Saunders, pp 32-42, 49-56
14. 14. Kerr JFR, Winterford CM, Harmon BV (1994) Apoptosis. Its significance in cancer and cancer therapy. Cancer 73:2013-2026
15. 15. Kuhn C, Boldt J, Talmadge EK, Crouch E, Vartio T, McDonald J (1989) An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 140:1693-1703
16. 16. Kuwano K, Hagimoto N, Nomoto Y, Kawasaki M, Kunitake R, Fujita M, Miyazaki H, Hara N (1997) p53 and p21 (Waf1/Cip1) mRNA expression associated with DNA damage and repair in acute immune complex alveolitis in mice. Lab Invest 76:161-169
17. Waf1/Cip/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 154:477-483
18. 18. Miyashita T, Krajewski S, Krajewski M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805
19. 19. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609-619
20. 20. Polunovsky VA, Chen B, Henke C, Snover D, Wendt C, Ingbar DH, Bitterman PB (1993) Role of mesenchymal cell death in lung remodeling after injury. J Clin Invest 92:388-397
21. 21. Pratt PC (1978) Pathology of adult respiratory distress syndrome. In: Thurlbeck WM, Abell MR (eds). The Lung: Structure, Function and Disease. Baltimore, Williams & Wilkins Co, pp 43-57
22. 22. Reed JC (1994) Bcl-2 and the regulation of programmed cells death. (Mini-review: cellular mechanisms of disease series). J Cell Biol 124:1-6
23. 23. Soini Y, Pääkkö P, Lehto V-P (1998) Histopathological evaluation of apoptosis in cancer (review). Am J Pathol 153:1041-1053
24. 24. Soini Y, Virkajärvi N, Lehto V-P, Pääkkö P (1996) Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Br J Cancer 73:1025-1030
25. 25. Törmänen U, Eerola A-K, Rainio P, Vähäkangas K, Soini Y, Sormunen R, Bloigu R, Lehto V-P, Pääkkö P (1995) Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res 55:5595-5602
26. 26. Turner-Warwick M, Burrows B, Johnson A (1980) Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 35:171-180
27. 27. Uhal BD, Joshi I, True AL, Mundle S, Raza A, Pardo A, Selman M (1995) Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. Am J Physiol 269 (Lung Cell Mol Physiol 13):L819-L828
28. 28. Wagenvoort CA (1980) Lung biopsy specimens in the evaluation of pulmonary vascular disease. Chest 77:614-625
29. 29. Yokoi T, Nojiri T, Kondoh Y, Taniguchi H, Takagi K, Ono K, Kakudo K (1998) Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in interstitial pneumonias (abstract). Arch Anat Cytol Pathol Clin Exp Pathol 46 (no. 5-6):594